Mark DeWitte
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 12
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 3
- Chemokine receptors and signaling 2
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Robert Corringham (4 shared papers)Geoffrey M. Anderson (1 shared paper)Yan Li (1 shared paper)Marian T. Nakada (1 shared paper)Susan Hoare (2 shared papers)Kellie A. Charles (2 shared papers)Frances R. Balkwill (2 shared papers)Uma Prabhakar (2 shared papers)
- Journals
- Blood (6 papers)Journal of Clinical Oncology (4 papers)European Journal of Cancer (2 papers)Toxicologic Pathology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Mark DeWitte
21 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Oncology 532
- Immunology 375
- Radiology, Nuclear Medicine and Imaging 212
- Hematology 86
- Cancer Research 99
Countries citing papers authored by Mark DeWitte
This map shows the geographic impact of Mark DeWitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark DeWitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark DeWitte more than expected).
Fields of papers citing papers by Mark DeWitte
This network shows the impact of papers produced by Mark DeWitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark DeWitte. The network helps show where Mark DeWitte may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark DeWitte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 195 | |
| 2 | 2003 | 146 | |
| 3 | 2008 | 140 | |
| 4 | A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. | 2008 | 122 |
| 5 | 2014 | 98 | |
| 6 | 2006 | 93 | |
| 7 | 2014 | 52 | |
| 8 | The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. | 2009 | 43 |
| 9 | 2001 | 41 | |
| 10 | 2004 | 41 | |
| 11 | 2008 | 31 | |
| 12 | 1994 | 20 | |
| 13 | 2008 | 16 | |
| 14 | 1997 | 11 | |
| 15 | 2012 | 10 | |
| 16 | 2015 | 9 | |
| 17 | 2012 | 8 | |
| 18 | 1997 | 6 | |
| 19 | Severe idiopathic congenital aplastic anemia: role of hematopoietic growth factors. | 1993 | 4 |
| 20 | 2007 | 3 |
About Mark DeWitte
Mark DeWitte is a scholar working on Oncology, Immunology, Hematology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers), Acute Myeloid Leukemia Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Chemokine receptors and signaling (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (532 citations), Immunology (375 citations), Radiology, Nuclear Medicine and Imaging (212 citations), Hematology (86 citations) and Cancer Research (99 citations). Mark DeWitte has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert Corringham, Geoffrey M. Anderson, Yan Li, Marian T. Nakada, Susan Hoare, Kellie A. Charles, Frances R. Balkwill, Uma Prabhakar, Carla de Boer and John M. Lambert. Their work appears in journals such as Blood, Journal of Clinical Oncology, European Journal of Cancer, Toxicologic Pathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.